5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.57▲ | 4.56▲ | 4.56▲ | 4.59▼ | 4.47▲ |
MA10 | 4.56▲ | 4.55▲ | 4.54▲ | 4.54▲ | 4.36▲ |
MA20 | 4.56▲ | 4.55▲ | 4.56▲ | 4.43▲ | 4.48▲ |
MA50 | 4.55▲ | 4.59▼ | 4.59▼ | 4.33▲ | 4.78▼ |
MA100 | 4.55▲ | 4.57▲ | 4.48▲ | 4.50▲ | 4.70▼ |
MA200 | 4.57▲ | 4.47▲ | 4.34▲ | 4.65▼ | 7.77▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.006▲ | 0.000▲ | 0.022▲ | 0.039▲ |
RSI | 63.809▲ | 53.410▲ | 52.118▲ | 56.955▲ | 50.995▲ |
STOCH | 91.190▲ | 83.186▲ | 52.655 | 60.917 | 62.909 |
WILL %R | 0.000▲ | 0.000▲ | -31.034 | -39.286 | -42.726 |
CCI | 111.610▲ | 123.635▲ | 33.974 | 40.603 | 52.286 |
CDL | $VNDA Doji Candlestick Pattern Detected | Set Alert |
Tuesday, June 10, 2025 05:00 AM
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in the first-in-human clinical trial to evaluate the safety and tolerability of VCA-894A, an antisense oligonucleotide ...
|
Friday, May 09, 2025 05:00 PM
HC Wainwright reissued their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently ...
|
Wednesday, May 07, 2025 01:32 PM
VANDA PHARMACEUTICALS ($VNDA) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.50 per share, beating estimates of -$0.61 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 4.58 | 4.58 | 4.48 | 4.58 | 237,961 |
13/06/25 | 4.57 | 4.62 | 4.51 | 4.51 | 362,068 |
12/06/25 | 4.58 | 4.645 | 4.52 | 4.63 | 266,976 |
11/06/25 | 4.69 | 4.72 | 4.58 | 4.58 | 296,191 |
10/06/25 | 4.585 | 4.70 | 4.49 | 4.665 | 336,454 |
09/06/25 | 4.65 | 4.80 | 4.56 | 4.59 | 589,973 |
06/06/25 | 4.43 | 4.62 | 4.405 | 4.61 | 497,482 |
05/06/25 | 4.46 | 4.52 | 4.3725 | 4.39 | 624,856 |
04/06/25 | 4.41 | 4.4554 | 4.375 | 4.44 | 352,530 |
03/06/25 | 4.30 | 4.3962 | 4.24 | 4.39 | 439,394 |
|
|
||||
|
|
||||
|
|